Last week colleagues from the Milner Institute and Korea Research Institute of Bioscience and Biotechnology (KRIBB) celebrated the signing of a new Memorandum of Understanding (MoU) that will open up exciting possibilities for collaboration. The new agreement will enable KRIBB to discuss establishing a European research outpost here in Cambridge and will focus on bringing together experts in cell and gene therapy, organoid screening and AI-enabled drug discovery.

The agreement with the Milner Institute was one of several new science and tech deals signed last week by the UK Secretary of State Michelle Donelan MP, Minister of Trade, Industry and Energy Bang Moon-kyu, and Minister of Science and ICT Lee Jong Ho. The commitments form a key part of the new UK-Republic of Korea Accord and includes an MoU between Innovate UK and the Korea Institute for Advancement of Technology (KIAT) that aims to unlock closer collaboration between both countries’ industries and researchers in key areas such as semiconductors.

 

Headshot of Cathy Tralau-Stewart

It is very exciting to announce this new agreement, which will enable KRIBB to start discussions around establishing new links here in Cambridge and collaborative research with the Milner. We hope this will also create more opportunities to bring talented researchers from Korea to Cambridge.

Cathy Tralau-Stewart

Executive Director, Milner Therapeutics Institute

MILNER THERAPEUTICS SYMPOSIUM

X